Cargando…
The Cervical Dystonia Impact Profile (CDIP-58): Can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria?
BACKGROUND: The United States Food and Drug Administration (FDA) are currently producing guidelines for the scientific adequacy of patient reported outcome measures (PROMs) in clinical trials, which will have implications for the selection of scales used in future clinical trials. In this study, we...
Autores principales: | Cano, Stefan J, Warner, Thomas T, Thompson, Alan J, Bhatia, Kailash P, Fitzpatrick, Ray, Hobart, Jeremy C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2538506/ https://www.ncbi.nlm.nih.gov/pubmed/18684327 http://dx.doi.org/10.1186/1477-7525-6-58 |
Ejemplares similares
-
CDiP technology for reverse engineering of sporadic Alzheimer’s disease
por: Kondo, Takayuki, et al.
Publicado: (2022) -
An international survey of patients with cervical dystonia
por: Comella, Cynthia, et al.
Publicado: (2015) -
Secondary Dystonia-Clinical Clues and Syndromic Associations
por: Schneider, Susanne A, et al.
Publicado: (2009) -
Pathogenesis of dystonia: is it of cerebellar or basal ganglia origin?
por: Kaji, Ryuji, et al.
Publicado: (2018) -
The genetics of dystonia: new twists in an old tale
por: Charlesworth, Gavin, et al.
Publicado: (2013)